| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2021-09-24 20:17:16 UTC |
|---|
| Update Date | 2021-09-24 20:17:16 UTC |
|---|
| HMDB ID | HMDB0304864 |
|---|
| Secondary Accession Numbers | None |
|---|
| Metabolite Identification |
|---|
| Common Name | Ripretinib |
|---|
| Description | Ripretinib belongs to the class of organic compounds known as phenylpyridines. These are polycyclic aromatic compounds containing a benzene ring linked to a pyridine ring through a CC or CN bond. Based on a literature review a significant number of articles have been published on Ripretinib. |
|---|
| Structure | CCN1C(=O)C(=CC2=C1C=C(NC)N=C2)C1=C(Br)C=C(F)C(NC(=O)NC2=CC=CC=C2)=C1 InChI=1S/C24H21BrFN5O2/c1-3-31-21-12-22(27-2)28-13-14(21)9-17(23(31)32)16-10-20(19(26)11-18(16)25)30-24(33)29-15-7-5-4-6-8-15/h4-13H,3H2,1-2H3,(H,27,28)(H2,29,30,33) |
|---|
| Synonyms | | Value | Source |
|---|
| N-{4-bromo-5-[1-ethyl-7-(methylimino)-2-oxo-1,2,6,7-tetrahydro-1,6-naphthyridin-3-yl]-2-fluorophenyl}-n'-phenylcarbamimidate | HMDB | | 1-(4-Bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-phenylurea | HMDB |
|
|---|
| Chemical Formula | C24H21BrFN5O2 |
|---|
| Average Molecular Weight | 510.367 |
|---|
| Monoisotopic Molecular Weight | 509.086266 |
|---|
| IUPAC Name | 3-{4-bromo-5-[1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl]-2-fluorophenyl}-1-phenylurea |
|---|
| Traditional Name | 3-{4-bromo-5-[1-ethyl-7-(methylamino)-2-oxo-1,6-naphthyridin-3-yl]-2-fluorophenyl}-1-phenylurea |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CCN1C(=O)C(=CC2=C1C=C(NC)N=C2)C1=C(Br)C=C(F)C(NC(=O)NC2=CC=CC=C2)=C1 |
|---|
| InChI Identifier | InChI=1S/C24H21BrFN5O2/c1-3-31-21-12-22(27-2)28-13-14(21)9-17(23(31)32)16-10-20(19(26)11-18(16)25)30-24(33)29-15-7-5-4-6-8-15/h4-13H,3H2,1-2H3,(H,27,28)(H2,29,30,33) |
|---|
| InChI Key | CEFJVGZHQAGLHS-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as phenylpyridines. These are polycyclic aromatic compounds containing a benzene ring linked to a pyridine ring through a CC or CN bond. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Pyridines and derivatives |
|---|
| Sub Class | Phenylpyridines |
|---|
| Direct Parent | Phenylpyridines |
|---|
| Alternative Parents | |
|---|
| Substituents | - 3-phenylpyridine
- N-phenylurea
- Naphthyridine
- Aminopyridine
- Bromobenzene
- Fluorobenzene
- Halobenzene
- Pyridinone
- Aryl bromide
- Aryl fluoride
- Aryl halide
- Monocyclic benzene moiety
- Imidolactam
- Benzenoid
- Heteroaromatic compound
- Lactam
- Urea
- Azacycle
- Organobromide
- Organohalogen compound
- Hydrocarbon derivative
- Organic oxide
- Carbonyl group
- Organic oxygen compound
- Amine
- Organofluoride
- Organonitrogen compound
- Organooxygen compound
- Organic nitrogen compound
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Predicted by Siyang on May 30, 2022 | 12.4785 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.17 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1580.3 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 213.7 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 92.8 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 152.3 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 68.5 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 333.2 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 604.0 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 134.4 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 828.3 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 393.2 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1729.2 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 314.6 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 258.8 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 511.2 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 125.6 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 213.8 seconds | 40023050 |
Predicted Kovats Retention IndicesDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Ripretinib,1TMS,isomer #1 | CCN1C(=O)C(C2=CC(NC(=O)NC3=CC=CC=C3)=C(F)C=C2Br)=CC2=CN=C(N(C)[Si](C)(C)C)C=C21 | 4174.6 | Semi standard non polar | 33892256 | | Ripretinib,1TMS,isomer #1 | CCN1C(=O)C(C2=CC(NC(=O)NC3=CC=CC=C3)=C(F)C=C2Br)=CC2=CN=C(N(C)[Si](C)(C)C)C=C21 | 3782.7 | Standard non polar | 33892256 | | Ripretinib,1TMS,isomer #1 | CCN1C(=O)C(C2=CC(NC(=O)NC3=CC=CC=C3)=C(F)C=C2Br)=CC2=CN=C(N(C)[Si](C)(C)C)C=C21 | 5315.4 | Standard polar | 33892256 | | Ripretinib,1TMS,isomer #2 | CCN1C(=O)C(C2=CC(N(C(=O)NC3=CC=CC=C3)[Si](C)(C)C)=C(F)C=C2Br)=CC2=CN=C(NC)C=C21 | 4018.7 | Semi standard non polar | 33892256 | | Ripretinib,1TMS,isomer #2 | CCN1C(=O)C(C2=CC(N(C(=O)NC3=CC=CC=C3)[Si](C)(C)C)=C(F)C=C2Br)=CC2=CN=C(NC)C=C21 | 3864.4 | Standard non polar | 33892256 | | Ripretinib,1TMS,isomer #2 | CCN1C(=O)C(C2=CC(N(C(=O)NC3=CC=CC=C3)[Si](C)(C)C)=C(F)C=C2Br)=CC2=CN=C(NC)C=C21 | 5408.1 | Standard polar | 33892256 | | Ripretinib,1TMS,isomer #3 | CCN1C(=O)C(C2=CC(NC(=O)N(C3=CC=CC=C3)[Si](C)(C)C)=C(F)C=C2Br)=CC2=CN=C(NC)C=C21 | 3940.8 | Semi standard non polar | 33892256 | | Ripretinib,1TMS,isomer #3 | CCN1C(=O)C(C2=CC(NC(=O)N(C3=CC=CC=C3)[Si](C)(C)C)=C(F)C=C2Br)=CC2=CN=C(NC)C=C21 | 3662.1 | Standard non polar | 33892256 | | Ripretinib,1TMS,isomer #3 | CCN1C(=O)C(C2=CC(NC(=O)N(C3=CC=CC=C3)[Si](C)(C)C)=C(F)C=C2Br)=CC2=CN=C(NC)C=C21 | 5302.1 | Standard polar | 33892256 | | Ripretinib,2TMS,isomer #1 | CCN1C(=O)C(C2=CC(N(C(=O)NC3=CC=CC=C3)[Si](C)(C)C)=C(F)C=C2Br)=CC2=CN=C(N(C)[Si](C)(C)C)C=C21 | 3928.1 | Semi standard non polar | 33892256 | | Ripretinib,2TMS,isomer #1 | CCN1C(=O)C(C2=CC(N(C(=O)NC3=CC=CC=C3)[Si](C)(C)C)=C(F)C=C2Br)=CC2=CN=C(N(C)[Si](C)(C)C)C=C21 | 3826.9 | Standard non polar | 33892256 | | Ripretinib,2TMS,isomer #1 | CCN1C(=O)C(C2=CC(N(C(=O)NC3=CC=CC=C3)[Si](C)(C)C)=C(F)C=C2Br)=CC2=CN=C(N(C)[Si](C)(C)C)C=C21 | 4922.0 | Standard polar | 33892256 | | Ripretinib,2TMS,isomer #2 | CCN1C(=O)C(C2=CC(NC(=O)N(C3=CC=CC=C3)[Si](C)(C)C)=C(F)C=C2Br)=CC2=CN=C(N(C)[Si](C)(C)C)C=C21 | 3833.6 | Semi standard non polar | 33892256 | | Ripretinib,2TMS,isomer #2 | CCN1C(=O)C(C2=CC(NC(=O)N(C3=CC=CC=C3)[Si](C)(C)C)=C(F)C=C2Br)=CC2=CN=C(N(C)[Si](C)(C)C)C=C21 | 3620.0 | Standard non polar | 33892256 | | Ripretinib,2TMS,isomer #2 | CCN1C(=O)C(C2=CC(NC(=O)N(C3=CC=CC=C3)[Si](C)(C)C)=C(F)C=C2Br)=CC2=CN=C(N(C)[Si](C)(C)C)C=C21 | 4840.1 | Standard polar | 33892256 | | Ripretinib,2TMS,isomer #3 | CCN1C(=O)C(C2=CC(N(C(=O)N(C3=CC=CC=C3)[Si](C)(C)C)[Si](C)(C)C)=C(F)C=C2Br)=CC2=CN=C(NC)C=C21 | 3805.4 | Semi standard non polar | 33892256 | | Ripretinib,2TMS,isomer #3 | CCN1C(=O)C(C2=CC(N(C(=O)N(C3=CC=CC=C3)[Si](C)(C)C)[Si](C)(C)C)=C(F)C=C2Br)=CC2=CN=C(NC)C=C21 | 3735.2 | Standard non polar | 33892256 | | Ripretinib,2TMS,isomer #3 | CCN1C(=O)C(C2=CC(N(C(=O)N(C3=CC=CC=C3)[Si](C)(C)C)[Si](C)(C)C)=C(F)C=C2Br)=CC2=CN=C(NC)C=C21 | 4849.8 | Standard polar | 33892256 | | Ripretinib,3TMS,isomer #1 | CCN1C(=O)C(C2=CC(N(C(=O)N(C3=CC=CC=C3)[Si](C)(C)C)[Si](C)(C)C)=C(F)C=C2Br)=CC2=CN=C(N(C)[Si](C)(C)C)C=C21 | 3776.0 | Semi standard non polar | 33892256 | | Ripretinib,3TMS,isomer #1 | CCN1C(=O)C(C2=CC(N(C(=O)N(C3=CC=CC=C3)[Si](C)(C)C)[Si](C)(C)C)=C(F)C=C2Br)=CC2=CN=C(N(C)[Si](C)(C)C)C=C21 | 3728.3 | Standard non polar | 33892256 | | Ripretinib,3TMS,isomer #1 | CCN1C(=O)C(C2=CC(N(C(=O)N(C3=CC=CC=C3)[Si](C)(C)C)[Si](C)(C)C)=C(F)C=C2Br)=CC2=CN=C(N(C)[Si](C)(C)C)C=C21 | 4472.9 | Standard polar | 33892256 | | Ripretinib,1TBDMS,isomer #1 | CCN1C(=O)C(C2=CC(NC(=O)NC3=CC=CC=C3)=C(F)C=C2Br)=CC2=CN=C(N(C)[Si](C)(C)C(C)(C)C)C=C21 | 4348.8 | Semi standard non polar | 33892256 | | Ripretinib,1TBDMS,isomer #1 | CCN1C(=O)C(C2=CC(NC(=O)NC3=CC=CC=C3)=C(F)C=C2Br)=CC2=CN=C(N(C)[Si](C)(C)C(C)(C)C)C=C21 | 3943.0 | Standard non polar | 33892256 | | Ripretinib,1TBDMS,isomer #1 | CCN1C(=O)C(C2=CC(NC(=O)NC3=CC=CC=C3)=C(F)C=C2Br)=CC2=CN=C(N(C)[Si](C)(C)C(C)(C)C)C=C21 | 5342.1 | Standard polar | 33892256 | | Ripretinib,1TBDMS,isomer #2 | CCN1C(=O)C(C2=CC(N(C(=O)NC3=CC=CC=C3)[Si](C)(C)C(C)(C)C)=C(F)C=C2Br)=CC2=CN=C(NC)C=C21 | 4245.8 | Semi standard non polar | 33892256 | | Ripretinib,1TBDMS,isomer #2 | CCN1C(=O)C(C2=CC(N(C(=O)NC3=CC=CC=C3)[Si](C)(C)C(C)(C)C)=C(F)C=C2Br)=CC2=CN=C(NC)C=C21 | 4053.5 | Standard non polar | 33892256 | | Ripretinib,1TBDMS,isomer #2 | CCN1C(=O)C(C2=CC(N(C(=O)NC3=CC=CC=C3)[Si](C)(C)C(C)(C)C)=C(F)C=C2Br)=CC2=CN=C(NC)C=C21 | 5363.2 | Standard polar | 33892256 | | Ripretinib,1TBDMS,isomer #3 | CCN1C(=O)C(C2=CC(NC(=O)N(C3=CC=CC=C3)[Si](C)(C)C(C)(C)C)=C(F)C=C2Br)=CC2=CN=C(NC)C=C21 | 4133.7 | Semi standard non polar | 33892256 | | Ripretinib,1TBDMS,isomer #3 | CCN1C(=O)C(C2=CC(NC(=O)N(C3=CC=CC=C3)[Si](C)(C)C(C)(C)C)=C(F)C=C2Br)=CC2=CN=C(NC)C=C21 | 3845.6 | Standard non polar | 33892256 | | Ripretinib,1TBDMS,isomer #3 | CCN1C(=O)C(C2=CC(NC(=O)N(C3=CC=CC=C3)[Si](C)(C)C(C)(C)C)=C(F)C=C2Br)=CC2=CN=C(NC)C=C21 | 5277.6 | Standard polar | 33892256 | | Ripretinib,2TBDMS,isomer #1 | CCN1C(=O)C(C2=CC(N(C(=O)NC3=CC=CC=C3)[Si](C)(C)C(C)(C)C)=C(F)C=C2Br)=CC2=CN=C(N(C)[Si](C)(C)C(C)(C)C)C=C21 | 4295.7 | Semi standard non polar | 33892256 | | Ripretinib,2TBDMS,isomer #1 | CCN1C(=O)C(C2=CC(N(C(=O)NC3=CC=CC=C3)[Si](C)(C)C(C)(C)C)=C(F)C=C2Br)=CC2=CN=C(N(C)[Si](C)(C)C(C)(C)C)C=C21 | 4197.3 | Standard non polar | 33892256 | | Ripretinib,2TBDMS,isomer #1 | CCN1C(=O)C(C2=CC(N(C(=O)NC3=CC=CC=C3)[Si](C)(C)C(C)(C)C)=C(F)C=C2Br)=CC2=CN=C(N(C)[Si](C)(C)C(C)(C)C)C=C21 | 4966.4 | Standard polar | 33892256 | | Ripretinib,2TBDMS,isomer #2 | CCN1C(=O)C(C2=CC(NC(=O)N(C3=CC=CC=C3)[Si](C)(C)C(C)(C)C)=C(F)C=C2Br)=CC2=CN=C(N(C)[Si](C)(C)C(C)(C)C)C=C21 | 4195.3 | Semi standard non polar | 33892256 | | Ripretinib,2TBDMS,isomer #2 | CCN1C(=O)C(C2=CC(NC(=O)N(C3=CC=CC=C3)[Si](C)(C)C(C)(C)C)=C(F)C=C2Br)=CC2=CN=C(N(C)[Si](C)(C)C(C)(C)C)C=C21 | 4021.4 | Standard non polar | 33892256 | | Ripretinib,2TBDMS,isomer #2 | CCN1C(=O)C(C2=CC(NC(=O)N(C3=CC=CC=C3)[Si](C)(C)C(C)(C)C)=C(F)C=C2Br)=CC2=CN=C(N(C)[Si](C)(C)C(C)(C)C)C=C21 | 4902.1 | Standard polar | 33892256 | | Ripretinib,2TBDMS,isomer #3 | CCN1C(=O)C(C2=CC(N(C(=O)N(C3=CC=CC=C3)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C(F)C=C2Br)=CC2=CN=C(NC)C=C21 | 4168.4 | Semi standard non polar | 33892256 | | Ripretinib,2TBDMS,isomer #3 | CCN1C(=O)C(C2=CC(N(C(=O)N(C3=CC=CC=C3)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C(F)C=C2Br)=CC2=CN=C(NC)C=C21 | 4134.0 | Standard non polar | 33892256 | | Ripretinib,2TBDMS,isomer #3 | CCN1C(=O)C(C2=CC(N(C(=O)N(C3=CC=CC=C3)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C(F)C=C2Br)=CC2=CN=C(NC)C=C21 | 4901.7 | Standard polar | 33892256 | | Ripretinib,3TBDMS,isomer #1 | CCN1C(=O)C(C2=CC(N(C(=O)N(C3=CC=CC=C3)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C(F)C=C2Br)=CC2=CN=C(N(C)[Si](C)(C)C(C)(C)C)C=C21 | 4310.1 | Semi standard non polar | 33892256 | | Ripretinib,3TBDMS,isomer #1 | CCN1C(=O)C(C2=CC(N(C(=O)N(C3=CC=CC=C3)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C(F)C=C2Br)=CC2=CN=C(N(C)[Si](C)(C)C(C)(C)C)C=C21 | 4254.3 | Standard non polar | 33892256 | | Ripretinib,3TBDMS,isomer #1 | CCN1C(=O)C(C2=CC(N(C(=O)N(C3=CC=CC=C3)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C(F)C=C2Br)=CC2=CN=C(N(C)[Si](C)(C)C(C)(C)C)C=C21 | 4626.8 | Standard polar | 33892256 |
|
|---|